Cancer cells adopt unprecedented strategies to produce a molecule that protects them from iron-dependent death

Researchers discovered that cancer cells employ novel mechanisms to synthesize spermine, a molecule that shields them from ferroptosis, a form of programmed cell death driven by iron. This finding, published in Nature on June 22, 2026, reveals that cancer cells can increase their production of spermine by upregulating specific enzymes involved in its synthesis. The study identified that these cancer cells not only produce more spermine but also exhibit a heightened reliance on this molecule for survival, particularly under conditions of iron overload. This enhanced production allows cancer cells to effectively sequester excess iron, thereby preventing the initiation of ferroptosis. The implications of this discovery extend to potential therapeutic strategies for both tissue damage and cancer treatment, by targeting the pathways cancer cells use to produce spermine or by interfering with spermine's iron-binding capabilities. Understanding this survival mechanism could pave the way for developing new drugs that selectively induce ferroptosis in cancer cells, leaving healthy cells unharmed. The research highlights a critical vulnerability in cancer cell metabolism that can be exploited for therapeutic intervention.